{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:42:36Z","timestamp":1793036556218,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tcm.2024.06.002","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T07:36:18Z","timestamp":1720942578000},"page":"34-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of genetic testing in management and prognosis of individuals with inherited cardiomyopathies"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9313-4172","authenticated-orcid":false,"given":"Sophie","family":"Hespe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Puranik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sweeting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4846-7676","authenticated-orcid":false,"given":"Jodie","family":"Ingles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41569-020-0428-2","article-title":"Epidemiology of the inherited cardiomyopathies","volume":"18","author":"McKenna","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"23","key":"10.1016\/j.tcm.2024.06.002_bib0002","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.tcm.2024.06.002_bib0003","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacep.2018.03.006","article-title":"Clinical spectrum of SCN5A mutations: long QT syndrome, brugada syndrome, and cardiomyopathy","volume":"4","author":"Wilde","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"10.1016\/j.tcm.2024.06.002_bib0004","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCGENETICS.116.001571","article-title":"New insights into the genetic basis of inherited arrhythmia syndromes","volume":"9","author":"Gray","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"issue":"25","key":"10.1016\/j.tcm.2024.06.002_bib0005","first-page":"e533","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.tcm.2024.06.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008877","article-title":"Validating an Idiopathic dilated cardiomyopathy diagnosis using cardiovascular magnetic resonance: the dilated cardiomyopathy precision medicine study","volume":"15","author":"Haas","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"23","key":"10.1016\/j.tcm.2024.06.002_bib0007","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.tcm.2024.06.002_bib0008","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.tcm.2024.06.002_bib0009","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","article-title":"Arrhythmogenic Cardiomyopathy","volume":"121","author":"Corrado","year":"2017","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.tcm.2024.06.002_bib0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the Task Force Criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2024.06.002_bib0011","series-title":"StatPearls [Internet]","article-title":"Left Ventricular Non-compaction Cardiomyopathy","author":"Singh","year":"2022"},{"issue":"14","key":"10.1016\/j.tcm.2024.06.002_bib0012","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/eurheartj\/ehz317","article-title":"A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults","volume":"41","author":"Ross","year":"2020","journal-title":"Eur Heart J"},{"issue":"2 Pt 1","key":"10.1016\/j.tcm.2024.06.002_bib0013","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcmg.2017.11.016","article-title":"The role of cardiovascular magnetic resonance imaging in the assessment of highly trained athletes","volume":"11","author":"Gati","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.tcm.2024.06.002_bib0014","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","article-title":"Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.tcm.2024.06.002_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.tcm.2024.06.002_bib0016","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/gim.2017.212","article-title":"Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience","volume":"20","author":"Bland","year":"2018","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.tcm.2024.06.002_bib0017","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ajhg.2017.04.015","article-title":"Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource","volume":"100","author":"Strande","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.tcm.2024.06.002_bib0018","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ajhg.2021.06.020","article-title":"Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution","volume":"108","author":"Stark","year":"2021","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.tcm.2024.06.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the clinical validity of hypertrophic cardiomyopathy genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ Genom Precis Med"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","article-title":"Evidence-based assessment of genes in dilated cardiomyopathy","volume":"144","author":"Jordan","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.tcm.2024.06.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003273","article-title":"International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework","volume":"14","author":"James","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.tcm.2024.06.002_bib0022","article-title":"The role of genetic testing in diagnosis and care of inherited cardiac conditions in a specialised multidisciplinary clinic [Internet]","author":"Stafford","year":"2022","journal-title":"medRxiv"},{"issue":"14","key":"10.1016\/j.tcm.2024.06.002_bib0023","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/eurheartj\/ehz669","article-title":"Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis","volume":"41","author":"Corrado","year":"2020","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.tcm.2024.06.002_bib0024","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/eurheartj\/ehaa141","article-title":"The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy","volume":"41","author":"James","year":"2020","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.tcm.2024.06.002_bib0025","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/509122","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2","volume":"79","author":"Syrris","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.tcm.2024.06.002_bib0026","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCGENETICS.113.000097","article-title":"Homozygous founder mutation in desmocollin-2 (DSC2) causes arrhythmogenic cardiomyopathy in the Hutterite population","volume":"6","author":"Gerull","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.tcm.2024.06.002_bib0027","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2020.03.006","article-title":"A homozygous DSC2 deletion associated with arrhythmogenic cardiomyopathy is caused by uniparental isodisomy","volume":"141","author":"Brodehl","year":"2020","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"10.1016\/j.tcm.2024.06.002_bib0028","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/jmedgenet-2021-107911","article-title":"Genotype-phenotype correlation in arrhythmogenic right ventricular cardiomyopathy-risk of arrhythmias and heart failure","volume":"59","author":"Christensen","year":"2022","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0029","doi-asserted-by":"crossref","first-page":"13791","DOI":"10.1038\/s41598-017-13737-x","article-title":"Arrhythmogenic cardiomyopathy related DSG2 mutations affect desmosomal cadherin binding kinetics","volume":"7","author":"Dieding","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.tcm.2024.06.002_bib0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcard.2018.11.004","article-title":"The complex molecular genetics of arrhythmogenic cardiomyopathy","volume":"284","author":"Celeghin","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2024.06.002_bib0031","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2018.06.105","article-title":"A founder homozygous DSG2 variant in East Asia results in ARVC with full penetrance and heart failure phenotype","volume":"274","author":"Chen","year":"2019","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2024.06.002_bib0032","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ejhf.1423","article-title":"High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"21","author":"Hermida","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.tcm.2024.06.002_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002241","article-title":"Desmoplakin gene variants and risk for arrhythmogenic cardiomyopathy","volume":"11","author":"Favre","year":"2018","journal-title":"Circ Genom Precis Med"},{"issue":"3","key":"10.1016\/j.tcm.2024.06.002_bib0034","first-page":"326","article-title":"Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study","volume":"21","author":"Augusto","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2024.06.002_bib0035","article-title":"Variant location is a novel risk factor for individuals with arrhythmogenic cardiomyopathy due to a desmoplakin (DSP) truncating variant","author":"Hoorntje","year":"2022","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.tcm.2024.06.002_bib0036","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2017.05.018","article-title":"Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: genotype-phenotype correlation","volume":"249","author":"Castelletti","year":"2017","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2024.06.002_bib0037","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/europace\/euu128","article-title":"Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype","volume":"16","author":"L\u00f3pez-Ayala","year":"2014","journal-title":"Europace"},{"issue":"14","key":"10.1016\/j.tcm.2024.06.002_bib0038","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.tcm.2024.06.002_bib0039","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/14779072.2020.1828064","article-title":"Naxos disease - a narrative review","volume":"18","author":"Leopoulou","year":"2020","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"18","key":"10.1016\/j.tcm.2024.06.002_bib0040","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/eurheartj\/ehl184","article-title":"Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis","volume":"27","author":"Antoniades","year":"2006","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.tcm.2024.06.002_bib0041","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1086\/521633","article-title":"A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy","volume":"81","author":"Asimaki","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/j.tcm.2024.06.002_bib0042","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tcm.2020.07.006","article-title":"Arrhythmogenic cardiomyopathy: an in-depth look at molecular mechanisms and clinical correlates","volume":"31","author":"Costa","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.tcm.2024.06.002_bib0043","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41436-021-01233-7","article-title":"The genetic architecture of Plakophilin 2 cardiomyopathy","volume":"23","author":"Dries","year":"2021","journal-title":"Genet Med"},{"issue":"7","key":"10.1016\/j.tcm.2024.06.002_bib0044","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jacc.2006.06.045","article-title":"Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"48","author":"Dalal","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2024.06.002_bib0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s13353-021-00647-y","article-title":"Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy","volume":"62","author":"Biernacka","year":"2021","journal-title":"J Appl Genet"},{"issue":"11","key":"10.1016\/j.tcm.2024.06.002_bib0046","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002355","article-title":"Concealed arrhythmogenic right ventricular cardiomyopathy in sudden unexplained cardiac death events","volume":"11","author":"Ingles","year":"2018","journal-title":"Circ Genom Precis Med"},{"issue":"22","key":"10.1016\/j.tcm.2024.06.002_bib0047","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.jacc.2022.09.029","article-title":"Concealed cardiomyopathy in autopsy-inconclusive cases of sudden cardiac death and implications for families","volume":"80","author":"Isbister","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2024.06.002_bib0048","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003302","article-title":"Clinical findings and diagnostic yield of arrhythmogenic cardiomyopathy through genomic screening of pathogenic or likely pathogenic desmosome gene variants","volume":"14","author":"Carruth","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0049","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41525-021-00211-x","article-title":"Genetic variants associated with inherited cardiovascular disorders among 13,131 asymptomatic older adults of European descent","volume":"6","author":"Lacaze","year":"2021","journal-title":"NPJ Genom Med"},{"issue":"Pt 4","key":"10.1016\/j.tcm.2024.06.002_bib0050","article-title":"LUMA interacts with emerin and influences its distribution at the inner nuclear membrane","volume":"121","author":"L","year":"2008","journal-title":"J Cell Sci [Internet]"},{"issue":"4","key":"10.1016\/j.tcm.2024.06.002_bib0051","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","article-title":"Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene","volume":"82","author":"Merner","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.tcm.2024.06.002_bib0052","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0004.2012.01919.x","article-title":"The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43","volume":"83","author":"Hodgkinson","year":"2013","journal-title":"Clin Genet"},{"issue":"3","key":"10.1016\/j.tcm.2024.06.002_bib0053","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003589","article-title":"Long-term clinical outcome of arrhythmogenic right ventricular cardiomyopathy in individuals with a p.S358L Mutation in TMEM43 following implantable cardioverter defibrillator therapy","volume":"9","author":"Hodgkinson","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"10.1016\/j.tcm.2024.06.002_bib0054","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.hrthm.2020.02.028","article-title":"Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy","volume":"17","author":"Paulin","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2024.06.002_bib0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijcard.2016.09.068","article-title":"Genetic basis of dilated cardiomyopathy","volume":"224","author":"P\u00e9rez-Serra","year":"2016","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2024.06.002_bib0056","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.cjca.2014.09.030","article-title":"Nonsense mutations in BAG3 are associated with early-onset dilated cardiomyopathy in French Canadians","volume":"30","author":"Chami","year":"2014","journal-title":"Can J Cardiol"},{"issue":"20","key":"10.1016\/j.tcm.2024.06.002_bib0057","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","article-title":"Dilated cardiomyopathy due to BLC2-Associated Athanogene 3 (BAG3) Mutations","volume":"72","author":"Dom\u00ednguez","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.tcm.2024.06.002_bib0058","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00441-014-2016-4","article-title":"Desmin in muscle and associated diseases: beyond the structural function","volume":"360","author":"Hnia","year":"2015","journal-title":"Cell Tissue Res"},{"issue":"10","key":"10.1016\/j.tcm.2024.06.002_bib0059","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.106.646778","article-title":"Prevalence of desmin mutations in dilated cardiomyopathy","volume":"115","author":"Taylor","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00401-012-1057-6","article-title":"Desminopathies: pathology and mechanisms","volume":"125","author":"Clemen","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.tcm.2024.06.002_bib0061","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-0004.2010.01512.x","article-title":"Desmin-related myopathy","volume":"80","author":"van Spaendonck-Zwarts","year":"2011","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.tcm.2024.06.002_bib0062","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10741-021-10172-z","article-title":"Filamin C in cardiomyopathy: from physiological roles to DNA variants","volume":"27","author":"Song","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"6","key":"10.1016\/j.tcm.2024.06.002_bib0063","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/humu.24004","article-title":"A mutation update for the FLNC gene in myopathies and cardiomyopathies","volume":"41","author":"Verdonschot","year":"2020","journal-title":"Hum Mutat"},{"issue":"22","key":"10.1016\/j.tcm.2024.06.002_bib0064","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2024.06.002_bib0065","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/heartjnl-2017-312338","article-title":"Lamin and the heart","volume":"104","author":"Captur","year":"2018","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.tcm.2024.06.002_bib0066","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0067","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"van Berlo","year":"2005","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"10.1016\/j.tcm.2024.06.002_bib0068","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","article-title":"Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals","volume":"106","author":"Kayvanpour","year":"2017","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2024.06.002_bib0069","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2024.06.002_bib0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy-A heart failure society of america practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.tcm.2024.06.002_bib0071","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","article-title":"Phospholamban: a crucial regulator of cardiac contractility","volume":"4","author":"MacLennan","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.tcm.2024.06.002_bib0072","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"10.1016\/j.tcm.2024.06.002_bib0073","article-title":"Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy","volume":"12","author":"Parikh","year":"2019","journal-title":"Circulation: Heart Failure"},{"issue":"13","key":"10.1016\/j.tcm.2024.06.002_bib0074","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","article-title":"RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling","volume":"138","author":"van den Hoogenhof","year":"2018","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.tcm.2024.06.002_bib0075","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/CIRCULATIONAHA.109.860171","article-title":"Cardiac titin: a multifunctional giant","volume":"121","author":"LeWinter","year":"2010","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.tcm.2024.06.002_bib0076","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006832","article-title":"Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene","volume":"13","author":"Akhtar","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"270","key":"10.1016\/j.tcm.2024.06.002_bib0077","doi-asserted-by":"crossref","first-page":"270ra6","DOI":"10.1126\/scitranslmed.3010134","article-title":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease","volume":"7","author":"Roberts","year":"2015","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.tcm.2024.06.002_bib0078","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jmedgenet-2020-107178","article-title":"Dilated cardiomyopathy caused by truncating titin variants: long-term outcomes, arrhythmias, response to treatment and sex differences","volume":"58","author":"Vissing","year":"2021","journal-title":"J Med Genet"},{"issue":"23","key":"10.1016\/j.tcm.2024.06.002_bib0079","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.jacc.2021.04.030","article-title":"Improved risk stratification for ventricular arrhythmias and sudden death in patients with nonischemic dilated cardiomyopathy","volume":"77","author":"Di Marco","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2024.06.002_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145284","article-title":"Prevalence of titin truncating variants in general population","volume":"10","author":"Akinrinade","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0081","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.119.039573","article-title":"Genomics-first evaluation of heart disease associated with titin-truncating variants","volume":"140","author":"Haggerty","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.tcm.2024.06.002_bib0082","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0083","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy-induced cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.tcm.2024.06.002_bib0084","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2018.03.462","article-title":"Genetic etiology for alcohol-induced cardiac toxicity","volume":"71","author":"Ware","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2024.06.002_bib0085","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3389\/fphys.2018.01372","article-title":"SCN5A variants: association with cardiac disorders","volume":"9","author":"Li","year":"2018","journal-title":"Front Physiol"},{"issue":"21","key":"10.1016\/j.tcm.2024.06.002_bib0086","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","article-title":"SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism","volume":"57","author":"McNair","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0087","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003432","article-title":"Arrhythmic phenotypes are a defining feature of dilated cardiomyopathy-associated SCN5A variants: a systematic review","volume":"15","author":"Peters","year":"2022","journal-title":"Circ Genom Precis Med"},{"issue":"16","key":"10.1016\/j.tcm.2024.06.002_bib0088","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jacc.2012.05.050","article-title":"R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy","volume":"60","author":"Mann","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2024.06.002_bib0089","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11886-022-01682-9","article-title":"The Cardiac Sarcomere and Cell Cycle","volume":"24","author":"Pettinato","year":"2022","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ppedcard.2010.11.006","article-title":"Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy","volume":"31","author":"Frazier","year":"2011","journal-title":"Prog Pediatr Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2024.06.002_bib0091","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.recesp.2015.06.028","article-title":"Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene","volume":"69","author":"Ripoll-Vera","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.tcm.2024.06.002_bib0092","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-genom-083118-015306","article-title":"Advances in the genetic basis and pathogenesis of sarcomere cardiomyopathies","volume":"20","author":"Yotti","year":"2019","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"24","key":"10.1016\/j.tcm.2024.06.002_bib0093","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2014.09.059","article-title":"Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations","volume":"64","author":"Coppini","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.tcm.2024.06.002_bib0094","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005191","article-title":"Incident atrial fibrillation is associated with MYH7 sarcomeric gene variation in hypertrophic cardiomyopathy","volume":"11","author":"Lee","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"14","key":"10.1016\/j.tcm.2024.06.002_bib0095","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.tcm.2024.06.002_bib0096","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cge.13157","article-title":"Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy","volume":"93","author":"Mathew","year":"2018","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.tcm.2024.06.002_bib0097","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001666","article-title":"Multiple gene variants in hypertrophic cardiomyopathy in the era of next-generation sequencing","volume":"10","author":"Burns","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"40","key":"10.1016\/j.tcm.2024.06.002_bib0098","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.tcm.2024.06.002_bib0099","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2024.06.002_bib0100","first-page":"ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.tcm.2024.06.002_bib0101","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurjpc\/zwac080","article-title":"Indications and utility of cardiac genetic testing in athletes","volume":"29","author":"Castelletti","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/eurheartj\/ehy730","article-title":"Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)","volume":"40","author":"Pelliccia","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.tcm.2024.06.002_bib0103","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13073-019-0616-z","article-title":"Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy","volume":"11","author":"Walsh","year":"2019","journal-title":"Genome Med"},{"issue":"24","key":"10.1016\/j.tcm.2024.06.002_bib0104","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1073\/pnas.1606950113","article-title":"Multidimensional structure-function relationships in human \u03b2-cardiac myosin from population-scale genetic variation","volume":"113","author":"Homburger","year":"2016","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173824000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173824000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:35:29Z","timestamp":1736469329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173824000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1050173824000537"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2024.06.002","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of genetic testing in management and prognosis of individuals with inherited cardiomyopathies","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2024.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}